Brentuximab vedotin - a highly potent Therapy in cutaneous T-Cell-Lymphoma

被引:0
|
作者
Pax, A. T.
Stadler, R.
机构
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:2 / 2
页数:1
相关论文
共 50 条
  • [1] Brentuximab vedotin - a highly potent Therapy for cutaneous T-Cell Lymphoma
    Pax, A. T.
    Stadler, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 (12): : E6 - E6
  • [2] Brentuximab vedotin - a Highly Potent Therapy for Cutaneous T-Cell-Lymphomas
    Pax, A.
    Stadler, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 21 - 21
  • [3] Brentuximab Vedotin in the Treatment of Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma
    Lauren Shea
    Neha Mehta-Shah
    Current Hematologic Malignancy Reports, 2020, 15 : 9 - 19
  • [4] Brentuximab Vedotin in the Treatment of Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma
    Shea, Lauren
    Mehta-Shah, Neha
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (01) : 9 - 19
  • [5] Brentuximab vedotin — a new standard for cutaneous T-cell lymphoma
    David Killock
    Nature Reviews Clinical Oncology, 2017, 14 : 460 - 460
  • [6] Modern aspects of therapy for cutaneous T-cell-lymphoma
    Nestle, FO
    Haffner, AC
    Schmid, MH
    Dummer, R
    Burg, G
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 127 (08) : 311 - 320
  • [7] Brentuximab vedotin in T-cell lymphoma
    Van der Weyden, Carrie
    Dickinson, Michael
    Whisstock, James
    Prince, H. Miles
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (01) : 5 - 19
  • [8] THERAPY OF CUTANEOUS T-CELL-LYMPHOMA WITH ALPHA-INTERFERONE
    LANG, MH
    ALTMEYER, P
    LODEMANN, E
    HOLZMANN, H
    ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1986, 61 (09): : 599 - 608
  • [9] THERAPY OF CUTANEOUS T-CELL-LYMPHOMA WITH ALPHA-INTERFERON
    LANG, M
    ALTMEYER, P
    HOLZMANN, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 110 (05) : 197 - 197